Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02859961 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 9, 2016
Last Update Posted : January 14, 2022
|
Sponsor:
CytoDyn, Inc.
Information provided by (Responsible Party):
CytoDyn, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | September 16, 2020 |
| Estimated Study Completion Date : | June 15, 2022 |